尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by OrbiMed Israel GP Ltd.. Officer active across 2 companies, notably 9 METERS BIOPHARMA, INC.. In total, 3 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €1.8m. Activity tracked since 11 May 2021. The latest transaction was disclosed on 3 January 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
OrbiMed Israel GP Ltd. is a declarant linked to 9 METERS BIOPHARMA, INC. and Chemomab Therapeutics Ltd. The 5 known filings, all included in the recent sample, concern sales for a total of EUR 2,751,650, over the period from 2021-05-13 to 2023-01-05.